BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/6/2018 1:35:45 PM | Browse: 1184 | Download: 1552
 |
Received |
|
2018-08-28 02:03 |
|
Peer-Review Started |
|
2018-08-28 07:22 |
|
To Make the First Decision |
|
2018-10-09 09:02 |
|
Return for Revision |
|
2018-10-11 01:35 |
|
Revised |
|
2018-10-16 22:12 |
|
Second Decision |
|
2018-11-14 09:56 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-11-15 02:43 |
|
Articles in Press |
|
2018-11-15 02:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-12-03 07:37 |
|
Publish the Manuscript Online |
|
2018-12-06 13:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ghania Sohail, Xiaoyu Xu, Mary C Christman and Thomas A Tompkins |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Thomas A Tompkins, Lallemand Health Solutions Inc., 6100 Avenue Royalmount, Montreal H4P 2R2, QC, Canada. ttompkins@lallemand.com |
| Key Words |
Clinical remission; Systematic review; Meta-analysis; Mesalazine; Sulfasalazine; Ulcerative colitis; Medilac-S® |
| Core Tip |
Growing evidence demonstrates the important role of probiotics in the treatment of ulcerative colitis (UC), however past reviews evaluating the efficacy of probiotics as UC treatment often demonstrate significant heterogeneity, making it difficult to interpret results accurately. In this systematic review and meta-analysis, only one disease state, one probiotic and one population are reviewed and a focused analysis is conducted on the effects of the probiotic Medilac-S® in conjunction with conventional drug therapy to improve symptoms of UC and induce clinical remission within a Chinese population. |
| Publish Date |
2018-12-06 13:35 |
| Citation |
Sohail G, Xu X, Christman MC, Tompkins TA. Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis. World J Clin Cases 2018; 6(15): 961-984 |
| URL |
http://www.wjgnet.com/2307-8960/full/v6/i15/961.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v6.i15.961 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
